Clinical Trial Update: Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma [NA]

View source ↗

Summary

Stanford-sponsored trial evaluated lymph node mapping using indocyanine green in patients with recurrent melanoma. The study is completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Stanford University | Conditions: Recurrent Melanoma | NA | Status: COMPLETED | Results posted: 2017-05-24